Cargando…
Prostate apoptosis response-4 is involved in the apoptosis response to docetaxel in MCF-7 breast cancer cells
Experimental evidence indicates that prostate apoptosis response-4 (Par-4, also known as PAWR) is a key regulator of cancer cell survival and may be a target for cancer-selective targeted therapeutics. Par-4 was first identified in prostate cancer cells undergoing apoptosis. Both intracellular and e...
Autores principales: | PEREIRA, MICHELLY C., DE BESSA-GARCIA, SIMONE A., BURIKHANOV, RAVSHAN, PAVANELLI, ANA CAROLINA, ANTUNES, LOURIVAL, RANGNEKAR, VIVEK M., NAGAI, MARIA A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035780/ https://www.ncbi.nlm.nih.gov/pubmed/23760770 http://dx.doi.org/10.3892/ijo.2013.1983 |
Ejemplares similares
-
Prostate apoptosis response 4 (PAR4) expression modulates WNT signaling pathways in MCF7 breast cancer cells: A possible mechanism underlying PAR4-mediated docetaxel chemosensitivity
por: De Bessa Garcia, Simone Aparecida, et al.
Publicado: (2017) -
Neoadjuvant administration of hydroxychloroquine in a phase 1 clinical trial induced plasma Par-4 levels and apoptosis in diverse tumors
por: Wang, Peng, et al.
Publicado: (2018) -
Arylquins Target Vimentin to Trigger Par-4 Secretion for Tumor Cell Apoptosis
por: Burikhanov, Ravshan, et al.
Publicado: (2014) -
Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis
por: Burikhanov, Ravshan, et al.
Publicado: (2017) -
Plant-derived SAC domain of PAR-4 (Prostate Apoptosis Response 4) exhibits growth inhibitory effects in prostate cancer cells
por: Sarkar, Shayan, et al.
Publicado: (2015)